Symposia: Chronic Lymphocytic Leukemias: Basic and Translational
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Lymphoid Leukemias, Biological therapies, Antibody Therapy, apoptosis, adult, Translational Research, CLL, Non-Biological therapies, Lymphomas, elderly, genomics, bioinformatics, B Cell lymphoma, Checkpoint Inhibitor, Diseases, immune mechanism, Immune Disorders, Therapies, Immunotherapy, immunology, aggressive lymphoma, Lymphoid Malignancies, computational biology, young adult , Biological Processes, molecular biology, Technology and Procedures, Study Population, Human, profiling, molecular testing, omics technologies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Lymphoid Leukemias, Biological therapies, Antibody Therapy, apoptosis, adult, Translational Research, CLL, Non-Biological therapies, Lymphomas, elderly, genomics, bioinformatics, B Cell lymphoma, Checkpoint Inhibitor, Diseases, immune mechanism, Immune Disorders, Therapies, Immunotherapy, immunology, aggressive lymphoma, Lymphoid Malignancies, computational biology, young adult , Biological Processes, molecular biology, Technology and Procedures, Study Population, Human, profiling, molecular testing, omics technologies
Monday, December 12, 2022: 10:30 AM-12:00 PM
La Nouvelle Orleans Ballroom AB
(Ernest N. Morial Convention Center)
Moderators:
Adrian Wiestner, MD, PhD, NIH, National Heart Lung Blood Institute
and
Andrew H. Lipsky, MD, Columbia University Medical Center
Disclosures:
Lipsky: AbbVie: Consultancy; AstraZeneca: Consultancy; Synthekine: Consultancy.
10:30 AM
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH